Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young.
Thomas J Oxley,J Mocco,Shahram Majidi,Christopher P. Kellner,Hazem Shoirah,I. Paul Singh,Reade De Leacy,Tomoyoshi Shigematsu,Travis R. Ladner,Kurt A. Yaeger,Maryna Skliut,Jesse Weinberger,Neha S. Dangayach,Joshua B. Bederson,Stanley Tuhrim,Johanna T Fifi +15 more
Reads0
Chats0
TLDR
Five patients younger than 50 years of age with large-vessel stroke and Covid-19 infection presented to a health system in New York City over a 2-week period with signs of stroke and infection.Abstract:
Stroke in Young Patients with Covid-19 Five patients younger than 50 years of age with large-vessel stroke and Covid-19 infection presented to a health system in New York City over a 2-week period....read more
Citations
More filters
Journal ArticleDOI
COVID-19 and Microvascular Disease: Pathophysiology of SARS-CoV-2 Infection With Focus on the Renin-Angiotensin System.
TL;DR: This critical review aimed to address a possible unifying mechanism underlying the diverse complications of COVID-19: microvascular dysfunction, with emphasis on the renin-angiotensin system.
Journal ArticleDOI
Acute ischemic stroke and COVID-19.
TL;DR: Ischemic stroke may be a presenting feature of COVID-19 and its etiology remains unclear, but severe CO VID-19 disease might increase the risk of large-artery strokes.
Journal ArticleDOI
A comprehensive review of imaging findings in COVID-19 - status in early 2021.
Ali Afshar-Oromieh,Helmut Prosch,Cornelia M. Schaefer-Prokop,Karl Peter Bohn,Ian Alberts,Clemens Mingels,Majda M. Thurnher,Paul Cumming,Paul Cumming,Kuangyu Shi,Alan A. Peters,Silvana Geleff,Xiaoli Lan,Feng Wang,Adrian Thomas Huber,Christoph Gräni,Johannes T. Heverhagen,Axel Rominger,Matthias Fontanellaz,Heiko Schöder,Andreas Christe,Stavroula Mougiakakou,Lukas Ebner +22 more
TL;DR: In this article, a machine learning-based approach was used for diagnosis of COVID-19 pneumonia in patients with the primary manifestation of pulmonary disease and the tissue distribution of the angiotensinconverting-enzyme 2 (ACE 2) receptor.
Journal ArticleDOI
Neurological and Neuropsychological Changes Associated with SARS-CoV-2 Infection: New Observations, New Mechanisms.
Muhammad Ali Haidar,Hussam Jourdi,Zeinab Haj Hassan,Ohanes Ashekyan,Manal Fardoun,Zena Wehbe,Dina Maaliki,Maya Wehbe,Stefania Mondello,Samar Abdelhady,Shima Shahjouei,Maya Bizri,Yehia Mechref,Mark S. Gold,Ghassan Dbaibo,Hassan Zaraket,Ali H. Eid,Firas Kobeissy,Firas Kobeissy +18 more
TL;DR: A review of the recent updates of the central nervous system (CNS) manifestations post SARS-CoV-2 infection along with possible mechanisms that lead to them is presented in this article.
Journal ArticleDOI
Neurobiology of COVID-19: how can the virus affect the brain?
Jaqueline S. Generoso,João Quevedo,Matias Cattani,Bruna F. Lodetti,Lucas Aires de Sousa,Allan Collodel,Alexandre Paim Diaz,Felipe Dal-Pizzol +7 more
TL;DR: In this paper, a review of the neurobiology of coronavirus and postmortem neuropathological hallmarks is presented to help define the manifestations and burden of COVID-19 in neurological and psychiatric symptoms during and after the pandemic.
References
More filters
Journal ArticleDOI
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Fei Zhou,Ting Yu,Ronghui Du,Guohui Fan,Ying Liu,Zhibo Liu,Jie Xiang,Yeming Wang,Bin Song,Xiaoying Gu,Xiaoying Gu,Lulu Guan,Yuan Wei,Li Hui,Xudong Wu,Jiuyang Xu,Shengjin Tu,Yi Zhang,Hua Chen,Bin Cao +19 more
TL;DR: Wang et al. as discussed by the authors used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death, including older age, high SOFA score and d-dimer greater than 1 μg/mL.
Journal ArticleDOI
Large artery ischaemic stroke in severe acute respiratory syndrome (SARS).
T. Umapathi,Ai Ching Kor,Narayanaswamy Venketasubramanian,C. C. Tchoyoson Lim,Boon Chuan Pang,Tseng Tsai Yeo,Cheng Chuan Lee,Poh Lian Lim,Poh Lian Lim,Kuperan Ponnudurai,Khoon Leong Chuah,Puay Hoon Tan,Dessmon Y.H. Tai,Sze Peng Brenda Ang +13 more
TL;DR: It is believed that increased vigilance against stroke and other thrombotic complications among critically-ill SARS patients in future outbreaks is needed, especially if treatment such as intravenous immunoglobulin, that increases pro-thrombosis tendency, is contemplated.
Journal ArticleDOI
Erythropoietin as candidate for supportive treatment of severe COVID-19.
Hannelore Ehrenreich,Karin Weissenborn,Martin Begemann,Martin Begemann,Markus Busch,Eduard Vieta,Kamilla W. Miskowiak +6 more
TL;DR: Evidence that supports the use of human recombinant erythropoietin (EPO) for ameliorating course and outcome of seriously ill COVID-19 patients is recap here and the research design for a double-blind placebo-controlled randomized clinical trial including severely affected patients is planned to start shortly.
Journal ArticleDOI
Revisiting the Protein C Pathway: An Opportunity for Adjunctive Intervention in COVID-19?
TL;DR: The objective of this study was to establish a baseline for the evaluation of the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis.
Journal ArticleDOI
COVID-19-associated pulmonary and cerebral thromboembolic disease
TL;DR: A case of a 79-year-old woman that presented with stroke and was found to have COVID-19 pneumonia and concomitant large burden pulmonary arterial clot is reported.
Related Papers (5)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang,Yeming Wang,Xingwang Li,Lili Ren,Jianping Zhao,Yi Hu,Li Zhang,Guohui Fan,Jiuyang Xu,Xiaoying Gu,Zhenshun Cheng,Ting Yu,Jia'an Xia,Yuan Wei,Wenjuan Wu,Xuelei Xie,Wen Yin,Li Hui,Min Liu,Yan Xiao,Hong Gao,Li Guo,Jungang Xie,Guang-Fa Wang,Rongmeng Jiang,Zhancheng Gao,Qi Jin,Jianwei Wang,Bin Cao +28 more